|Podcasts|September 17, 2021
- December 2021
- Volume 15
- Issue 6
COVID-19 Pandemic Emphasizes Disparities in Cancer Care
Author(s)Brielle Benyon
“We’ve had periods of time where things were shut down. We do have telemedicine, that was expanded, but telemedicine doesn’t work for everyone. If you don’t have internet access, if you don’t have the ability to understand the technology….”
Advertisement
For this episode of “The Vitals,” we spoke with Chastity Washington, MPH, CHES, Center for Cancer Health Equity, Ohio State University, about how the COVID-19 pandemic has exacerbated preexisting disparities in cancer care. Chastity spoke to our team about the direct and indirect impacts of COVID 19 on disadvantaged communities, vaccine hesitancy amongst those communities, and more.
Articles in this issue
almost 5 years ago
Collaboration, Determination Improves Cancer Screenings in Rural Areasalmost 5 years ago
Continuing Education: December 2021almost 5 years ago
Cancer Care Costs US Billions— Mostly in Drug ExpensesAdvertisement
Related to this article
Beth Faiman, PhD, and Sikander Ailawadhi, MD, discuss clinic workflows, safety checks, and at-home dosing potential for on-body isatuximab.
Erika Hamilton, MD, breaks down liver monitoring, diarrhea, creatinine shifts, and oral adherence with maintenance tucatinib in HER2+ MBC.
ABUS matched handheld ultrasound on cancer detection in women with dense breasts while lowering recall and short-interval follow-up rates.
Long-term QUILT-3.032 data in BCG-unresponsive NMIBC with CIS show durable responses for some patients and a long, surveillance-heavy course.
The approval in stage II/III MSI-H/dMMR rectal cancer rests on AZUR-1, in which 71% of patients needed no treatment beyond dostarlimab.
Dr. Andrew Pecora on leading the first IV oncolytic virus trial, building a top-50 cancer center, and using AI to fix the cost of cancer care.
Eppie Bass, APRN, explains how nurses can counsel patients on flu-like symptoms vs warning signs with nogapendekin alfa inbakicept-pmln and BCG.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Grants Accelerated Approval to Dostarlimab in dMMR Rectal Cancer
2
Tucatinib Maintenance for HER2+ Breast Cancer: What Nurses, PAs Should Know
3
Anktiva Plus BCG: 84% of Responders Cystectomy-Free at 3 Years
4
Automated Breast Ultrasound Tied to Fewer False-Positives in Dense Breasts
5